GeminIQ Website Logo

Viewing NRC free

Subscribe for full history, 50+ metrics, screener, watchlist...

NRC HEALTH

NRC

Companies in Services-Commercial Physical & Biological Research

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets Current
Cash And Cash Equivalents At Carrying Value
3425343027422
Accounts Receivable Net Current
111113121111111011121412
Prepaid Expense Current
644563556466
Income Taxes Receivable
010000100000
Other Assets Current
011211111101
Assets Current
202020252020211720242541
Property Plant And Equipment And Finance Lease Rig…
404041424038363432282623
Intangible Assets Net Excluding Goodwill
222233311122
Goodwill
666666666666666262626262
Capitalized Contract Cost Net Noncurrent
322222-11122
Operating Lease Right Of Use Asset
-11112-22210
Other Assets Noncurrent
332234623345
Deferred Income Tax Assets Net
---------000
Assets
135135136141135133132119121122120134
Liabilities Current
Notes Payable Current
444435488755
Lines Of Credit Current
----4-597-5-
Accounts Payable Current
211121312112
Employee Related Liabilities Current
777655545455
Accrued Liabilities Current
334655656554
Dividends Payable Current
443333333333
Contract With Customer Liability Current
171618161616171515151615
Accrued Income Taxes Current
2110000020--
Other Liabilities Current
010111111111
Business Combination Contingent Consideration Liab…
-----11--0--
Liabilities Current
383739363836444649364134
Long Term Notes Payable
747576775958452628291415
Deferred Income Tax Liabilities Net
663454444455
Other Liabilities Noncurrent
333444444432
Liabilities
121121121120106101977984736256
Stockholders Equity
Business Combination Contingent Consideration Liab…
-----00--0--
Preferred Stock Value
000000000000
Common Stock Value
000000000000
Additional Paid In Capital Common Stock
186184182181181180180180180178177177
Retained Earnings Accumulated Deficit
-18-17-15-17-14-17-21-24-27-31-36-17
Treasury Stock Common Value
-----------82-82
Treasury Stock Value
-154-153-152-143-137-132-125-116-116-99--
Stockholders Equity
131414213031354037495878
Liabilities And Stockholders Equity
135135136141135133132119121122120134
Allowance For Doubtful Accounts Receivable Current
000000000000
Accumulated Other Comprehensive Income Loss Foreig…
-----0---0--
Preferred Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Preferred Stock Shares Authorized
222222222222
Preferred Stock Shares Issued
000000000000
Common Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Common Stock Shares Authorized
110110110110110110110110110110110110
Common Stock Shares Issued
323232323131313131313131
Shares Outstanding
232323232323232424242525
Treasury Stock Common Shares
999988877766

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20269.35%17.43%----------
20254.00%29.29%7.73%-2.72%-11.15%-22.11%15.58%28.03%44.56%23.13%23.85%37.15%
2024-2.33%-19.76%-13.78%8.31%6.94%-14.22%-1.65%-12.22%-9.55%-28.39%-13.06%0.53%
2023----0.49%11.33%1.82%2.44%-2.05%-0.71%-2.20%-16.50%-23.94%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.52
0.55
0.53
0.70
0.54
0.55
0.47
0.37
0.41
0.67
0.61
1.21
Quick Ratio
0.37
0.44
0.41
0.57
0.39
0.45
0.36
0.26
0.28
0.56
0.47
1.05
Working Capital
-18.49M
-16.41M
-18.17M
-10.61M
-17.37M
-16.26M
-23.58M
-28.78M
-28.84M
-11.84M
-16.06M
7.25M
Leverage & Debt
Debt to Equity
8.97
8.64
8.48
5.63
3.56
3.24
2.81
1.96
2.27
1.50
1.08
0.72
Interest Coverage TTM
3.82
4.74
6.68
8.25
12.13
13.56
17.48
24.73
32.45
46.46
46.16
41.44
Debt Ratio
0.90
0.90
0.89
0.85
0.78
0.76
0.74
0.66
0.69
0.60
0.52
0.42
Efficiency & Turnover
Asset Turnover TTM
1.03
1.03
1.04
1.08
1.10
1.12
1.14
1.16
1.16
1.18
1.17
1.10
Days Sales Outstanding TTM
29.17
29.44
31.24
29.23
29.00
29.89
32.32
27.38
31.38
32.97
36.62
30.73
Receivables Turnover TTM
12.51
12.40
11.69
12.49
12.59
12.21
11.29
13.33
11.63
11.07
9.97
11.88
Per Share Metrics
Diluted EPS TTM
0.41
0.52
0.74
0.79
1.05
1.04
1.14
1.22
1.27
1.26
1.16
1.18
Free Cash Flow Per Share TTM
0.53
0.44
0.26
0.15
0.65
0.81
1.06
0.95
1.08
0.91
0.84
0.86
Dividend Per Share TTM
0.54
0.49
0.50
0.49
0.49
0.48
0.49
1.52
1.52
1.48
1.60
0.72
Margin Metrics
Gross Profit Margin TTM
-
-
-
-
-
-
-
-
100.83%
100.58%
100.59%
100.68%
Operating Profit Margin TTM
14.11%
16.44%
19.78%
19.78%
24.79%
24.60%
25.88%
26.86%
26.99%
26.95%
27.28%
28.11%
Net Profit Margin TTM
6.52%
8.44%
11.76%
12.78%
17.13%
17.32%
18.79%
20.01%
20.60%
20.84%
19.33%
19.65%
Growth Metrics
Net Revenue Growth (1Y)
-1.88%
-3.96%
-3.50%
-4.08%
-4.15%
-3.72%
-3.07%
-1.47%
-1.46%
-1.97%
-1.98%
-2.19%
Net Income Growth (1Y)
-62.68%
-53.19%
-39.57%
-38.74%
-20.27%
-19.98%
-5.82%
0.32%
0.47%
-2.61%
-17.35%
-19.29%
EPS Growth (1Y)
-60.67%
-50.43%
-35.23%
-35.46%
-17.16%
-17.15%
-2.49%
3.29%
3.48%
-1.09%
-16.83%
-17.64%
Valuation Metrics
P/E TTM
40.65
35.61
16.85
20.52
11.65
16.04
18.92
17.59
29.10
29.21
35.21
33.22
P/B TTM
27.21
29.52
19.26
17.25
9.51
12.71
14.79
12.80
23.92
18.48
17.49
12.47
P/S TTM
2.65
3.01
1.98
2.62
2.00
2.78
3.55
3.52
5.99
6.09
6.81
6.53
Market Cap
367.26M
413.05M
275.69M
367.84M
282.04M
397.63M
512.23M
514.72M
883.62M
904.61M
1.01B
969.31M
Enterprise Value
442.75M
487.95M
353.51M
443.52M
344.74M
456.08M
562.40M
556.46M
923.99M
934.64M
1.03B
966.78M
Calculated Values
Free Cash Flow TTM
11.46M
9.77M
5.65M
3.30M
14.94M
19.18M
25.18M
22.70M
25.68M
22.33M
20.53M
21.25M
Net Debt
75.49M
74.90M
77.82M
75.68M
62.70M
58.45M
50.17M
41.74M
40.37M
30.03M
20.00M
-2.53M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-02-17Purchase
Owner: Harrison, Shane R
Title: EVP & Chief Financial Officer
Shares: 8,000
Price/Share: $12.27
Value: $98,160.00
Shares Owned: 8,000
Relationship: Officer
Ownership: Indirect
2025-07-31Purchase
Owner: Freeman, Jordan Nicole
Title: Chief Accounting Officer
Shares: 771
Price/Share: $12.97
Value: $9,999.87
Shares Owned: 771
Relationship: Officer
Ownership: Direct
2025-05-12Purchase
Owner: Beans, Patrick E
Title: -
Shares: 2,500
Price/Share: $13.59
Value: $33,975.00
Shares Owned: 35,003
Relationship: TenPercentOwner
Ownership: Direct
2024-03-01Sale
Owner: Common, Property Trust
Title: -
Shares: 598,653
Price/Share: $40.54
Value: $24,269,392.62
Shares Owned: 3,854,284
Relationship: TenPercentOwner
Ownership: Indirect
2024-01-05Sale
Owner: Amandla, Mk Trust
Title: -
Shares: 2,614
Price/Share: $40.20
Value: $105,082.80
Shares Owned: 3,831,362
Relationship: TenPercentOwner
Ownership: Indirect

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
46.87%
Inst. Shares: 10,216,646
Shares Outstanding: 21,799,000
2025-12-31
45.08%
Inst. Shares: 10,090,506
Shares Outstanding: 22,383,000
2025-09-30
47.06%
Inst. Shares: 10,413,971
Shares Outstanding: 22,130,000
2025-06-30
48.32%
Inst. Shares: 10,948,738
Shares Outstanding: 22,658,000
2025-03-31
46.80%
Inst. Shares: 10,750,247
Shares Outstanding: 22,972,000

NRC HEALTH (NRC) — SEC Financial Statements & Analysis

NRC HEALTH (NRC) is a services-commercial physical & biological research company, incorporated in DE. NRC HEALTH trades on NRC: Nasdaq as: NRC. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), NRC HEALTH reported a -1.88% year-over-year revenue growth, a Gross Profit Margin of 100.83% (TTM), a Debt-to-Equity ratio of 8.97x, a Price-to-Sales (P/S) ratio of 2.65x (TTM), a Price-to-Book (P/B) ratio of 27.21 (TTM), at a market cap of $367.26M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
-1.88%
Gross Profit Margin TTM
100.83%
Debt To Equity
8.97x
P/S TTM
2.65x
P/B TTM
27.21
Market Cap
$367.26M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is NRC HEALTH in?

NRC HEALTH (NRC) operates in the Services-Commercial Physical & Biological Research industry.

What is NRC's market cap?

NRC HEALTH (NRC) has a market capitalization of $367.26M as of 2026-03-31.

What is NRC's P/E ratio?

NRC HEALTH (NRC)'s trailing twelve month P/E ratio is 40.65x as of 2026-03-31.

What exchange does NRC trade on?

NRC HEALTH (NRC) trades on the NRC: Nasdaq.

Where is NRC HEALTH incorporated?

NRC HEALTH is incorporated in DE.

Research Faster.
Invest Smarter.

NRC HEALTH (NRC) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.